2017
DOI: 10.1016/s1470-2045(17)30026-8
|View full text |Cite|
|
Sign up to set email alerts
|

Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium

Abstract: Treatment with chemotherapy, radiotherapy, or surgery that involves reproductive organs can cause impaired spermatogenesis, testosterone deficiency, and physical sexual dysfunction in male pubertal, adolescent, and young adult cancer survivors. Guidelines for surveillance and management of potential adverse effects could improve cancer survivors' health and quality of life. Surveillance recommendations vary considerably, causing uncertainty about optimum screening practices. This clinical practice guideline re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
159
0
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 175 publications
(167 citation statements)
references
References 56 publications
6
159
0
2
Order By: Relevance
“…Primary gonadal failure with androgen deficiency and impaired spermatogenesis may be the result of the tumor itself (testis tumor), or its treatment. Surgery, chemotherapy or radiation to the testes may all lead to testicular dysfunction due to direct damage to Leydig-, Sertoli- or the testicular germ cells [7, 31]. Indirect damage may also cause dysfunction of the Sertoli or Leydig cells, such as by vascular damage, damage by changes in hormone concentrations, growth factors or the structure of the seminiferous tubule structure that will indirectly mediate the effects of chemo-/radiotherapy on the germ cells.…”
Section: Primary Gonadal Failure In Male Ccs (Table 1)mentioning
confidence: 99%
See 2 more Smart Citations
“…Primary gonadal failure with androgen deficiency and impaired spermatogenesis may be the result of the tumor itself (testis tumor), or its treatment. Surgery, chemotherapy or radiation to the testes may all lead to testicular dysfunction due to direct damage to Leydig-, Sertoli- or the testicular germ cells [7, 31]. Indirect damage may also cause dysfunction of the Sertoli or Leydig cells, such as by vascular damage, damage by changes in hormone concentrations, growth factors or the structure of the seminiferous tubule structure that will indirectly mediate the effects of chemo-/radiotherapy on the germ cells.…”
Section: Primary Gonadal Failure In Male Ccs (Table 1)mentioning
confidence: 99%
“…There is good published evidence for impaired spermatogenesis in males after treatment with busulphan, cyclophosphamide, chlormethine, ifosfamide, fludarabine/melphalan and procarbazine [7]. Similar to the studies performed in females, as in most studies patients were treated with combination therapy, it remains difficult to determine the absolute risk of a single agent.…”
Section: Primary Gonadal Failure In Male Ccs (Table 1)mentioning
confidence: 99%
See 1 more Smart Citation
“…In CCS, as well as adults who are survivors of childhood cancer, the risk of clinical metabolic syndrome is high [26]. Metabolic syndrome (MS) is characterized by a clustering of hypertension, dyslipidemia, type 2 diabetes or preclinical conditions, and obesity.…”
Section: Complications After Childhood/adolescent Cancer Treatmentmentioning
confidence: 99%
“…As a result, adult survivors of childhood cancer may suffer from cardiomyopathy, heart valve and conduction disorders [14,15], increased cardiovascular risk factors including hypertension, dyslipidemia [16][17][18], and obesity [19,20], pulmonary disorders [21,22], endocrine disorders [23] including hypothalamic-pituitary-adrenal disorders [24], diabetes mellitus [25], ovarian and Leydig cell dysfunction [26], and hypothyroidism [27]. Survivors of childhood cancer are also at increased risk for neurocognitive and neurosensory impairment including ocular degeneration, hearing loss and neuropathy [28][29][30][31], metabolic disturbances (abnormal blood counts, liver and kidney dysfunction, and osteoporosis) [28][29][30]32,33], transfusion-associated infections [30], and increased risk of subsequent neoplasm [14].…”
Section: Introductionmentioning
confidence: 99%